{
    "2018-10-31": [
        [
            {
                "time": "2023-10-31",
                "original_text": "国信医药|三季报点评】乐普医疗：业绩持续高增长，期待可降解支架获批",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "三季报",
                        "高增长",
                        "可降解支架",
                        "获批"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-31",
                "original_text": "东北证券：上调乐普医疗评级至买入",
                "features": {
                    "keywords": [
                        "东北证券",
                        "乐普医疗",
                        "评级",
                        "买入"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-31",
                "original_text": "医疗保健：基药目录调整 利好新增品种放量",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "基药目录",
                        "调整",
                        "新增品种",
                        "放量"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-31",
                "original_text": "从哪里跌倒从哪里涨起来！白酒、医药等白马消费股强势归来？",
                "features": {
                    "keywords": [
                        "白酒",
                        "医药",
                        "白马消费股",
                        "强势归来"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "消费"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-31",
                "original_text": "市值20强前三季业绩大比拼：上药营收超千亿 恒瑞净利近30亿",
                "features": {
                    "keywords": [
                        "市值20强",
                        "上药",
                        "恒瑞",
                        "营收",
                        "净利"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-31",
                "original_text": "2018版基药目录点评：从“保基本”到“保临床价值”",
                "features": {
                    "keywords": [
                        "基药目录",
                        "保基本",
                        "保临床价值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-31",
                "original_text": "上调评级至买入策略选股（10月31日）",
                "features": {
                    "keywords": [
                        "上调评级",
                        "买入",
                        "策略选股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}